Your search for proton pump inhibitor returned 13 results

Proton pump inhibitor use is associated with shorter survival among patients with non-small cell lung cancer treated with pembrolizumab monotherapy.

The findings highlight the value of routine medication assessment.

Is the use of proton pump inhibitors associated with empyema and lung abscess? Presenters at CHEST 2022 analyzed a large data base to address this question.

Is the use of proton pump inhibitors associated with empyema and lung abscess? Presenters at CHEST 2022 analyzed a large data base to address this question.

Clear management guidelines are needed for AKI during immune checkpoint inhibitor therapy, according to investigators.

A team of investigators evaluated the effects of concomitant use of PPIs and advanced therapy on health care resources in patients with IBD.

While food allergies may affect response to the medication, environmental allergies do not, the report says.

The application is supported by data from the pivotal phase 3 PHALCON-EE trial which compared the efficacy and safety of vonoprazan to lansoprazole in patients with erosive esophagitis.

Increased incidence of CAP was noted in stroke patients using PPIs.

Study is the largest to explore this potential safety issue to date.